Chaetoglobosin A

1. Core Information[1]
English Name: Chaetoglobosin A
Chinese Name (pinyin): Mao Qiu Jun Su A
CAS No.: 50335-03-0
Molecular Formula: C32H36N2O5
Molecular Weight: 528.6 g/mol
SMILE:CC1CC=CC2C3C(O3)(C(C4C2(C(=O)C=CC(=O)C(C(=C1)C)O)C(=O)NC4CC5=CNC6=CC=CC=C65)C)C
2. International Nomenclature & Identifiers
2.1 IUPAC Name
(1R,3E,6R,7E,9S,11E,13R,14S,16R,17S,18R,19S)-6-hydroxy-19-(1H-indol-3-ylmethyl)-7,9,16,17-tetramethyl-15-oxa-20-azatetracyclo[11.8.0.01,18.014,16]henicosa-3,7,11-triene-2,5,21-trione
2.2 InChI
InChI=1S/C32H36N2O5/c1-17-8-7-10-22-29-31(4,39-29)19(3)27-24(15-20-16-33-23-11-6-5-9-21(20)23)34-30(38)32(22,27)26(36)13-12-25(35)28(37)18(2)14-17/h5-7,9-14,16-17,19,22,24,27-29,33,37H,8,15H2,1-4H3,(H,34,38)/b10-7+,13-12+,18-14+/t17-,19-,22-,24-,27-,28+,29-,31+,32+/m0/s1
2.3 InChlKey
OUMWCYMRLMEZJH-VOXRAUTJSA-N
2.4 Canonical SMILES
CC1CC=CC2C3C(O3)(C(C4C2(C(=O)C=CC(=O)C(C(=C1)C)O)C(=O)NC4CC5=CNC6=CC=CC=C65)C)C
2.5 Isomeric SMILES
C[C@H]\1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2(C(=O)/C=C/C(=O)[C@@H](/C(=C1)/C)O)C(=O)N[C@H]4CC5=CNC6=CC=CC=C65)C)C
3. Spectroscopic Data
3.1 13C Nuclear Magnetic Resonance (13C NMR)
3.2 1H Nuclear Magnetic Resonance (1H NMR)
4. Research Progress on Chaetoglobosin A
4.1 Biosynthesis & Regulation
Chaetoglobosin A is a macrocyclic alkaloid with antifungal, antiparasitic, and anticancer properties.[2] Low yields and production costs have limited broader adoption. Recent work identified the _CgMfs1_ gene encoding a major facilitator superfamily transporter that influences biosynthesis and secretion; deletion reduces titers whereas overexpression raises output to 298.77 mg/L.[2]
4.2 Fermentation Optimization
Optimizing fermentation media via uniform design yielded a carbon/nitrogen combination of sucrose 17 g/L, starch 6 g/L, peptone 0.5 g/L with a 13-day culture time.[3] Ethyl acetate extraction (3-day soak) followed by silica gel chromatography provided efficient isolation, with optimal eluent and developing systems defined.

4.3 Straw-Based Fermentation
To reduce costs, a corn-straw-based fermentation/purification system was developed. Optimal conditions (straw 11.66 g, NH4Cl 0.67 g, 25.5 °C) produced 3.7647 mg of chaetoglobosin A.[4] This approach lowers expense while enhancing yield.
4.4 Genetic Engineering
Overexpressing the polyketide synthase chain-extension gene _Cger_ significantly boosts production, whereas disruption of _CghdI_—a negative regulator—further elevates final titers.[4]

4.5 Application Potential
Chaetoglobosin A suppresses numerous plant pathogens and exhibits antitumor activity, indicating promise in biopesticide and pharmaceutical applications.[5] In vivo tests demonstrate effective control of potato dry rot, underscoring agricultural value.[4]
In summary, advances in biosynthetic regulation, fermentation optimization, straw-based production, and strain engineering provide a solid foundation for agricultural and biomedical deployment. Continued exploration of mechanistic and process innovations will support efficient manufacturing.
References
- [1] http://www.kehuaai.com/productInfo/174966
- [2] Zhao S, Lin C, Cheng M, Zhang K, Wang Z, Zhao T, Yang Q. New insight into the production improvement and resource generation of chaetoglobosin A in Chaetomium globosum. Microb Biotechnol. 2022 Oct;15(10):2562-2577.
- [3] Ruan Lulu, Cheng Jingli, Lu Yifu, et al. Optimization of chaetoglobosin A fermentation and extraction. Agrochemicals, 2011, 50(12):4.
- [4] Jiang Cheng. Regulation of chaetoglobosin A biosynthesis and fermentation optimization. Harbin Institute of Technology, 2025.
- [5] Lu Yifu. Extraction, isolation, and bioactivity of Chaetomium fermentation products. Zhejiang University of Technology, 2010.
All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.
Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen
Phone: 400-856-5689
Email: kehuaai@kehuaai.com
Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.
ICP Record No.: 粤ICP备2024241782号